共 50 条
- [31] Upadacitinib in Crohn's disease: real-world experience MINERVA GASTROENTEROLOGY, 2024, 70 (04): : 442 - 445
- [32] Patients with Crohn's disease treated with ustekinumab vs. vedolizumab in real-world settings JOURNAL OF CROHNS & COLITIS, 2020, 14 : S630 - S630
- [33] Real World Experience of Ustekinumab for Induction and Maintenance of Remission in Crohn's Disease: A UK Single Center Experience AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S490 - S490
- [34] Disease course and fate of Crohn's perianal fistula patients following failure of initial biologic therapy: real-world lessons on the impact of refractory disease from a tertiary centre cohort JOURNAL OF CROHNS & COLITIS, 2020, 14 : S353 - S353
- [36] An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn's Disease BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 237 - 245
- [38] Treatment patterns, persistence with therapy, and outcomes of ustekinumab in Crohn's disease: Real-world data analysis JGH OPEN, 2022, 6 (02): : 120 - 125
- [40] Efficacy of Ustekinumab in the treatment of patients with Crohn's disease with failure to previous conventional or biologic therapy: an observational real-life study JOURNAL OF CROHNS & COLITIS, 2021, 15 : S522 - S522